Quick Answer
Astrana Health, Inc. reported Diluted EPS of $0.46 per share for fiscal year 2025.
Astrana Health, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.46 | -48.9% |
| 2024 | $0.90 | -30.2% |
| 2023 | $1.29 | +30.3% |
| 2022 | $0.99 | -34.9% |
| 2021 | $1.52 | +50.5% |
| 2020 | $1.01 | +159.0% |
| 2019 | $0.39 | +34.5% |
| 2018 | $0.29 | -67.8% |
| 2017 | $0.90 | +119.5% |
| 2016 | $0.41 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.01 | -97.0% | -94.7% |
| June 30, 2025 | $0.19 | -52.5% | +35.7% |
| March 31, 2025 | $0.14 | -54.8% | -57.6% |
| September 30, 2024 | $0.33 | -29.8% | -17.5% |
| June 30, 2024 | $0.40 | +42.9% | +29.0% |
| March 31, 2024 | $0.31 | +10.7% | -34.0% |
| September 30, 2023 | $0.47 | -6.0% | +67.9% |
| June 30, 2023 | $0.28 | +7.7% | +0.0% |
- Astrana Health, Inc. showed a decrease of -48.9% in Diluted EPS compared to the prior fiscal year.
- Over the 2016–2025 period, Astrana Health, Inc.’s diluted eps has grown by 12.2% (from $0.41 per share to $0.46 per share).
- The most recent figure is from Astrana Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: